| Serial Number | 88514961 |
| Word Mark | SAREPTA |
| Filing Date | Monday, July 15, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 4, 2021 |
| Registration Number | 6342349 |
| Registration Date | Tuesday, May 4, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 25, 2020 |
| Goods and Services | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 18, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, July 12, 2012 |
| First Use In Commerce Date | Wednesday, October 15, 2014 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, May 4, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Friday, April 2, 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, April 1, 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, March 19, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, March 1, 2021 | USE AMENDMENT FILED |
| Friday, March 19, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, March 1, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, October 22, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 20, 2020 | EXTENSION 1 GRANTED |
| Tuesday, October 20, 2020 | EXTENSION 1 FILED |
| Tuesday, October 20, 2020 | TEAS EXTENSION RECEIVED |
| Tuesday, April 21, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 25, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 25, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 5, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 17, 2020 | ASSIGNED TO LIE |
| Tuesday, January 14, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, January 13, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 13, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 13, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 3, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 3, 2019 | NON-FINAL ACTION E-MAILED |
| Thursday, October 3, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, September 30, 2019 | ASSIGNED TO EXAMINER |
| Friday, July 19, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, July 18, 2019 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Thursday, July 18, 2019 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Thursday, July 18, 2019 | NEW APPLICATION ENTERED IN TRAM |